Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study
Abuín-Fernández, Jose; Tapia-Guerrero, María José; López-Urdiales, Rafael; Herranz-Antolín, Sandra; García-Almeida, Jose Manuel; García-Malpartida, Katherine; Ferrer-Gómez, Mercedes; Cancer-Minchot, Emilia; Luengo-Pérez, Luis Miguel; Álvarez-Hernández, Julia; Valera, Carmen Aragón; Ocón-Bretón, Julia; García-Manzanares, Álvaro; Bretón-Lesmes, Irene; Serrano-Aguayo, Pilar; Pérez-Ferre, Natalia; López-Gómez, Juan José; Olivares-Alcolea, Josefina; Arraiza-Irigoyen, Carmen; Tejera Pérez, Cristina; Martínez-González, Jorge Daniel; Urioste-Fondo, Ana; Abad-González, Ángel Luis; Molina-Puerta, María José; Zugasti-Murillo, Ana; Parra-Barona, Juan; López-Cobo, Irela; Olveira-Fuster, And Gabriel
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
URI: http://hdl.handle.net/20.500.11940/16316
PMID: 32471262
DOI: 10.3390/nu12061566
ISSN: 2072-6643
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2020Título de revista
Nutrients
Tipo de contenido
Journal Article
DeCS
nutrición parenteral | aceites de pescado | anciano | hígado | insulina | ácidos grasos | triglicéridos | mediana edad | glucosa sanguínea | humanos | diabetes mellitus | hipoglicemiantesMeSH
Middle Aged | Humans | Fish Oils | Triglycerides | Hypoglycemic Agents | Blood Glucose | Liver | Parenteral Nutrition | Diabetes Mellitus | Insulin | Fatty Acids | AgedResumen
There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality.
![](/xmlui/themes/Mirage2//images/final_lines.png)